Suchergebnisse - "Alikarami, Fatemeh"

PubPharm (20)

1

Oncogenic RAS-Pathway Activation Drives Oncofetal Reprogramming and Creates Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia

enthalten in: bioRxiv.org | 2023

von Hartmann, M. | Schönung, M. | Rajak, J. | +36

2

Clonal evolution mediates Menin-inhibitor resistance inKMT2A-rearranged leukemias

enthalten in: bioRxiv.org | 2023

von Mahdavi, L. | Lenard, A. | Xie, H. | +12

3

Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia

enthalten in: Cancer discovery | 2022

von Liu, Y. | Li, Q. | Alikarami, F. | +29

4

Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia

enthalten in: iScience | 2022

von Pingul, B. | Huang, H. | Chen, Q. | +7

5

Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia

enthalten in: Blood | 2022

von Chen, C. | Yu, W. | Alikarami, F. | +22

CommentIn: Blood. 2022 Apr 7;139(14):2096-2097. - PMID 35389444

6

MITI minimum information guidelines for highly multiplexed tissue images

enthalten in: Nature methods | 2022

von Schapiro, D. | Yapp, C. | Sokolov, A. | +136

7

ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency

enthalten in: Molecular cell | 2021

von Cao, Z. | Budinich, K. | Huang, H. | +19

CommentIn: Mol Cell. 2021 Sep 2;81(17):3445-3446. - PMID 34478652

8

Menin is necessary for long term maintenance of meningioma-1 driven leukemia

enthalten in: Leukemia | 2021

von Libbrecht, C. | Xie, H. | Kingsley, M. | +7

9

Single-cell multi-omics reveals elevated plasticity and stem-cell-like blasts relevant to the poor prognosis of KMT2A-rearranged leukemia

enthalten in: bioRxiv.org | 2020

von Chen, C. | Yu, W. | Alikarami, F. | +20

10

DNA repair pathways as guardians of the genome : Therapeutic potential and possible prognostic role in hematologic neoplasms

enthalten in: DNA repair | 2020

von Rahimian, E. | Amini, A. | Alikarami, F. | +3